ArticleRevista medica del Instituto Mexicano del Seguro Social2025
[2018-2024 Cancer Trends in Pathology of a Hospital in Eastern Mexico].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cancer is one of the leading causes of mortality in both Mexico and the world, and its incidence continues to rise. Therefore, maintaining up-to-date records of cancer diagnoses at both local and national levels is essential. Objective: To analyze malignant neoplasm diagnoses issued by the Pathology Department of a tertiary care hospital in the eastern region of Mexico. Material and methods: Observational, descriptive study. Cancer diagnoses registered in the Pathology Department of the Hospital de Especialidades, Centro Médico Nacional "General de División Manuel Ávila Camacho," in Puebla, Mexico, were analyzed for the period 2018-2024. Results: Since 2018, a higher number of cases have been observed in women, accounting for 60-64% of total diagnoses. In 2024, the most frequent cancers in the general population were breast, prostate, and skin cancer. Among women, the most common were breast, thyroid/parathyroid, and skin cancers, while in men, prostate, kidney, and skin cancers predominated. A significant increase in diagnoses was recorded in 2024, particularly for breast, thyroid/parathyroid, colorectal, ovarian, kidney, and lung cancer in women, and for prostate, kidney, colorectal, bladder, and thyroid/parathyroid cancer in men. Conclusions: Access to regional cancer diagnosis data in Mexico is essential for establishing effective strategies for cancer control, early detection, and timely treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.